Schrödinger, Inc. ($SDGR)
Akinsanya Karen – President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Shares
27,576
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 25, 2026
EPS:Est: -0.13
Transaction Details
| Insider | Akinsanya Karen |
|---|---|
| Title | President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships |
| Transaction Date | Mar 2, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 3, 2026 |
| Shares Purchased | 27,576 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 73,528 |
| Derivative | No |
| Accession Number | 0001797672-26-000001 |
| Document | View SEC Filing |